Stolper Co trimmed its position in Aflac Incorporated (NYSE:AFL – Free Report) by 0.6% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 80,425 shares of the financial services provider’s stock after selling 467 shares during the period. Aflac makes up approximately 2.9% of Stolper Co’s investment portfolio, making the stock its 7th largest holding. Stolper Co’s holdings in Aflac were worth $8,992,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently modified their holdings of the company. Y.D. More Investments Ltd bought a new stake in Aflac in the 2nd quarter valued at approximately $25,000. Atwood & Palmer Inc. raised its holdings in shares of Aflac by 80.0% in the first quarter. Atwood & Palmer Inc. now owns 315 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 140 shares during the last quarter. OFI Invest Asset Management bought a new stake in shares of Aflac in the first quarter worth $29,000. Dixon Mitchell Investment Counsel Inc. acquired a new position in Aflac during the first quarter worth $34,000. Finally, Fairscale Capital LLC bought a new position in Aflac in the second quarter valued at $54,000. 67.44% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In related news, Director Thomas J. Kenny sold 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total value of $197,880.00. Following the completion of the sale, the director now directly owns 18,158 shares in the company, valued at approximately $1,796,552.52. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 0.90% of the company’s stock.
Aflac Price Performance
Aflac (NYSE:AFL – Get Free Report) last posted its earnings results on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.23. Aflac had a return on equity of 16.22% and a net margin of 28.35%. The company had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $4.10 billion. During the same quarter last year, the firm earned $1.58 earnings per share. The company’s revenue was down .7% on a year-over-year basis. Equities research analysts predict that Aflac Incorporated will post 6.76 earnings per share for the current year.
Aflac Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Monday, September 2nd. Shareholders of record on Wednesday, August 21st were given a dividend of $0.50 per share. The ex-dividend date was Wednesday, August 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.79%. Aflac’s payout ratio is presently 21.16%.
Analyst Ratings Changes
AFL has been the topic of several analyst reports. Evercore ISI boosted their price target on shares of Aflac from $84.00 to $90.00 and gave the stock an “underperform” rating in a research report on Thursday, September 26th. Barclays started coverage on shares of Aflac in a report on Wednesday, September 4th. They set an “underweight” rating and a $96.00 target price on the stock. Jefferies Financial Group cut their price target on shares of Aflac from $84.00 to $83.00 and set a “hold” rating for the company in a research note on Friday, June 28th. Citigroup boosted their price objective on shares of Aflac from $84.00 to $93.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 23rd. Finally, TD Cowen started coverage on shares of Aflac in a research note on Wednesday. They issued a “hold” rating and a $102.00 target price for the company. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $97.53.
Check Out Our Latest Analysis on AFL
About Aflac
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Articles
- Five stocks we like better than Aflac
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity
- Using the MarketBeat Stock Split Calculator
- Autodesk Named a “Top Pick” by Morgan Stanley—Is It Time to Buy?
- What Are Dividend Challengers?
- 4 Quirky ETFs With Big Potential for Impressive Gains
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.